Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening (NCT06549036) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
United States228 participantsStarted 2026-08-14
Plain-language summary
The project will investigate the efficacy of a Veteran-peer-navigator-led decision coaching (PDC) program to promote Shared Decision Making (SDM) for prostate cancer screening among Veterans at the Veterans Health Administration (VA). Prostate cancer is commonly screen detected using PSA, a non-specific test which has led to modest population-level survival benefits at the cost of over-detection of low-risk disease. This trade off in outcomes is ideally addressed using SDM which can be challenging to implement in time constrained primary care office visits. The investigators propose the evaluation of a PDC intervention to promote SDM for PSA screening to improve both access and quality of care for Veterans. The investigators results will enhance understanding of the efficacy, cost-effectiveness, and sustainability of PDC interventions for SDM promotion across communication formats in the VA. Lessons learned through this proposal will not only improve quality of care for PSA screening but also will suggest a paradigm for dissemination of SDM across preventive services.
Who can participate
Age range
40 Years – 69 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Veteran patient participants:
* Age 40-69 years old
* Veteran
* Male
* Attending VANYHHS-Manhattan for routine primary care appointment
Providers:
* Primary care provider at VA New York Harbor Healthcare System (VANYHHS)
* Caring for patients that fit inclusion criteria
Exclusion Criteria:
Veteran Patients:
* Patients seen within 9 months of other PSA tests
* Patients seen within 180 days after primary diagnosis of urinary obstruction, prostatitis, hematuria, other disorder of prostate, unexplained weight loss, or lumbar back pain
* Patients with a prior diagnosis of prostate cancer (ICD-10-CM C61)
* Patients visiting their provider for any indication other than a well-visit appointment
Providers:
\- Providers who do not treat adult male patients (e.g. OB/Gyns, pediatricians)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Decisional Conflict
Timeframe: Up to 3 months
2
Patient Knowledge Survey Score
Timeframe: Day 1
3
Decision Quality Score
Timeframe: Day 1
4
Prostate-specific Antigen (PSA) Screening Rates
Timeframe: Up to Month 3
5
Percentage of Participants Who Make Informed Choice (Knowledge Survey + Measure of Informed Choice Attitudes Scale)